Article summary
Peyton Nyquvest is the CEO of Numinus, a Canadian publicly-traded company that is involved in psychedelic synthesis, research and treatment. Numinous recently partnered with MAPS Public Benefit Corporation to host [β¦] The post Psychedelic Treatment in Canada: Interview with Payton Nyquvest of Numinus appeared first on Psychedelic Times.
Continue to the original publication for the complete article.